|
FUNDING OPPORTUNITIES
HHS Secretary Kathleen Sebelius and NIH Director Francis Collins announced the new program this morning. In its pilot phase, this initiative will match outstanding researchers with more than 20 molecular compounds from Pfizer, AstraZeneca and Eli Lilly to explore how such compounds might be put to use in treating patients.
Reminder: FOAs for Revision Supplements
See below for the links to the five FOAs for revision supplements for evidence- based research related to human subjects protection. The turn-around time is very short with applications due on May 25, 2012. One announcement is specifically for UL1 applications funded by NCATS (PAS-12-167). However, the other FOAs focused on awards funded by other ICs may offer opportunities to individuals at CTSA institutions, although all are competing for same funding pool.
|
|
REMINDERS
Training Program in Translational Investigation Enrollment Deadline
UCLA CTSI Training Program in Translational Investigation, formerly the NCRR K30, is accepting applications to its two-year, part-time certificate program and to its master's degree program in clincial research. The latter program is suitable for individuals planning a career in academic medicine. The application deadline for both programs is May 15. More information can be found here.
|
